The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The activin A‐follistatin system: potent regulator of human extracellular matrix mineralization
Abstract
Bone quality is an important determinant of osteoporosis, and proper osteoblast differentiation plays an important role in the control and maintenance of bone quality. We investigated the impact of activin signaling on human osteoblast differentiation, extracellular matrix formation, and mineralization. Ac‐tivins belong to the transforming growth factor‐β su‐perfamily and activin A treatment strongly inhibited mineralization in osteoblast cultures, whereas the ac‐tivin antagonist follistatin increased mineralization. Os‐teoblasts produced activin A and follistatin in a differentiation‐dependent manner, leading to autocrine regulation of extracellular matrix formation and mineralization. In addition, mineralization in a vascular smooth muscle cell‐based model for pathological calcification was inhibited. Comparative activin A and fol‐listatin gene expression profiling showed that activin signaling changes the expression of a specific range of extracellular matrix proteins prior to the onset of mineralization, leading to a matrix composition with reduced or no mineralizing capacity. These findings demonstrate the regulation of osteoblast differentiation and matrix mineralization by the activin A‐follista‐tin system, providing the possibility to control bone quality as well as pathological calcifications such as atherosclerosis by using activin A, follistatin, or analogs thereof.—Eijken M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., van der Spek P. J., Visser, J. A., de Jong F. H., Pols, H. A. P., van Leeuwen J. P. T. M. The activin A‐follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 21, 2949–2960 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Growth Factor-β1 to the Bone
Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0001 · Cited by 710
Functional analysis of activins during mammalian development
Matzuk, M. M., Kumar, T. R., Vassalli, A., Bickenbach, J. R., Roop, D. R., Jaenisch, R., & Bradley, A. (1995) · Nature · doi:10.1038/374354a0 · Cited by 578
Reciprocal Roles of Msx2 in Regulation of Osteoblast and Adipocyte Differentiation
Ichida, F., Nishimura, R., Hata, K., Matsubara, T., Ikeda, F., Hisada, K., Yatani, H., Cao, X., Komori, T., Yamaguchi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403621200 · Cited by 173
Osteoclast synthesis and secretion and activation of latent transforming growth factor β
Oursler, M. J. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090402 · Cited by 153
Research works printed but not linked: 54
- 10.1056/NEJMra053077 · DOI · Paper page
- Robey P. G., 2006, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
- 10.1161/hh2401.101070 · DOI · Paper page
- 10.1172/JCI117205 · DOI · Paper page
- 10.1161/01.ATV.0000133194.94939.42 · DOI · Paper page
- 10.1210/er.2002-0023 · DOI · Paper page
- 10.1002/jbmr.5650090611 · DOI · Paper page
- 10.1093/emboj/20.9.2254 · DOI · Paper page
- 10.1038/sj.emboj.7600067 · DOI · Paper page
- 10.1046/j.1432-1327.2000.01828.x · DOI · Paper page
- 10.1177/153537020623100507 · DOI · Paper page
- 10.1016/j.mce.2004.02.010 · DOI · Paper page
- 10.1172/JCI115827 · DOI
- 10.1074/jbc.270.11.6308 · DOI
- 10.1038/344868a0 · DOI · Paper page
- 10.2337/diabetes.53.8.2024 · DOI
- 10.1128/MCB.11.1.250 · DOI
- 10.1016/j.tem.2005.01.003 · DOI · Paper page
- 10.1126/science.2106159 · DOI · Paper page
- 10.1038/35006129 · DOI · Paper page
- 10.1210/en.138.7.2928 · DOI
- 10.1016/S0021-9258(19)49702-0 · DOI
- 10.1006/bbrc.1993.2006 · DOI
- 10.1210/endo.143.1.8580 · DOI
- 10.1016/S8756-3282(99)00152-0 · DOI
- 10.1007/s00223-001-2037-3 · DOI
- 10.1016/S0021-9258(18)42930-4 · DOI
- 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T · DOI
- 10.1210/me.2004-0212 · DOI
- 10.1016/j.mce.2005.11.034 · DOI
- 10.1093/emboj/17.11.3091 · DOI · Paper page
- 10.1074/jbc.M111023200 · DOI · Paper page
- 10.1093/bioinformatics/bth495 · DOI
- 10.1006/geno.2002.6748 · DOI · Paper page
- 10.1161/01.ATV.15.11.2003 · DOI · Paper page
- 10.1073/pnas.95.16.9337 · DOI · Paper page
- 10.1016/S0925-4773(97)00673-4 · DOI · Paper page
- 10.1016/S8756-3282(98)00139-2 · DOI
- 10.1007/s00467-004-1658-y · DOI
- 10.1051/rnd:2005031 · DOI
- 10.1016/S8756-3282(00)00307-0 · DOI
- 10.1016/S0303-7207(01)00496-8 · doi:10.1016/s0303-7207(01)00496-8
- 10.1038/374360a0 · DOI · Paper page
- 10.1210/mend.12.1.0053 · DOI · Paper page
- 10.1016/0006-291X(89)92795-2 · DOI · Paper page
- 10.1083/jcb.127.6.1767 · DOI
- 10.1016/S0014-4827(03)00213-1 · DOI · Paper page
- 10.1002/jcb.10272 · DOI
- Tenenbaum H. C., 1987, Chondroitin sulfate inhibits calcification of bone formed in vitro, Bone Miner., 2, 43
- 10.1097/01.mnh.0000168335.29381.23 · doi:10.1097/01.mnh.0000168335.29381.23
- 10.1161/01.CIR.101.8.850 · DOI · Paper page
- 10.1161/01.RES.85.10.931 · DOI
- 10.1016/0303-7207(94)03451-X · doi:10.1016/0303-7207(94)03451-x
- 10.1172/JCI24140 · doi:10.1172/jci24140 · Paper page
Cited by
Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation
Li, Z., Hassan, M. Q., Jafferji, M., Aqeilan, R. I., Garzon, R., Croce, C. M., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Lian, J. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809787200 · Cited by 589
Wu, M., Wu, S., Chen, W., & Li, Y.-P. (2024) · Cell Research · doi:10.1038/s41422-023-00918-9 · Cited by 445
Millward, D. J. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000238 · Cited by 368
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
Baron, R., & Hesse, E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2332 · Cited by 320
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
Metadata
- Authors
- Eijken, M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., van der Spek, P. J., Visser, J. A., de Jong, F. H., Pols, H. A. P., & van Leeuwen, J. P. T. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-04-20
- Volume
- 21
- Issue
- 11
- Pages
- 2949-2960
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2169715549
- Cited by
- 174
- References
- 4
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The activin A‐follistatin system: potent regulator of human extracellular matrix mineralization. https://app.cochat.ai/papers/10.1096/fj.07-8080com
- The paper
- Eijken, M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., van der Spek, P. J., Visser, J. A., de Jong, F. H., Pols, H. A. P., & van Leeuwen, J. P. T. M. (2007). The activin A‐follistatin system: potent regulator of human extracellular matrix mineralization. The FASEB Journal. https://doi.org/10.1096/fj.07-8080com
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.